7 research outputs found
Vivostat Platelet-Rich FibrinÂź for Complicated or Chronic Wounds-A Pilot Study
Vivostat Platelet-Rich FibrinÂź (PRF) is an autologous platelet concentrate used for the local treatment of chronic or complicated wounds. Still, its application for this indication is not evidence-based. Therefore, we performed this monocentric retrospective pilot study investigating the clinical outcome of a local treatment of chronic or complicated wounds in 35 patients (23 male, 12 female, mean age 68.7 years) treated with Vivostat PRFÂź. This study population is the largest among published studies analyzing the clinical efficacy of Vivostat PRFÂź on chronic wounds so far. Using the perpendicular method we divided the wounds into three sizes (30 cm2). The clinical efficacy of the Vivostat PRF treatment was the primary endpoint and was divided into three groups of increasing degrees of wound improvement: (1) no improvement of the wound (wound area was not reduced > 10% under Vivostat PRFÂź treatment), (2) improvement of the wound (reduced area > 10% under Vivostat PRFÂź treatment) and (3) complete epithelialization (wounds that were completely re-epithelialized after Vivostat PRFÂź treatment). We included patients' diagnosis and concomitant diseases (peripheral arterial occlusive disease (PAOD)), chronic venous insufficiency (CVI)), diabetic foot syndrome (DFS)) in our data analysis in order to investigate their potential impact on the wound healing capacity of Vivostat PRFÂź. Our results show that in the entire study population, 13 out of 35 (37.1%) patients experienced wound improvement and 14 out of 35 (40%) patients showed complete epithelialization of their wound under Vivostat PRFÂź treatment. In summary, 77.1% of the treated patients benefited from the Vivostat PRFÂź therapy
Colonic Fluid and Electrolyte Transport 2022: An Update
Colonic epithelial cells are responsible for maintaining a delicate balance between luminal secretion and the absorption of fluids and ions. This review aims to discuss and update the model of colonic electrolyte secretion and absorption via the cystic fibrosis transmembrane regulator (CFTR), epithelial sodium channel (ENaC), Na-K-Cl cotransporters (NKCC1 and 2), Na-H exchangers (NHE1â4), colonic H,KATPase, and several other key components involved in multi-level transepithelial ion transport. Developments in our understanding of the activity, regulation, localization, and relationships of these ion transporters and their interactions have helped forge a more robust understanding of colonic ion movement that accounts for the colonic epitheliumâs role in mucosal pH modulation, the setting of osmotic gradients pivotal for fluid retention and secretion, and cell death regulation. Deviations from homeostatic ion transport cause diarrhea, constipation, and epithelial cell death and contribute to cystic fibrosis, irritable bowel syndrome (IBS), ulcerative colitis, and cancer pathologies. Signal transduction pathways that regulate electrolyte movement and the regulatory relationships between various sensors and transporters (CFTR as a target of CaSR regulation and as a regulator of ENaC and DRA, for example) are imperative aspects of a dynamic and comprehensive model of colonic ion homeostasis
Recommended from our members
Sex differences in social brain neural responses in autism: temporal profiles of configural face-processing within data-driven time windows
Acknowledgements: This research received funding from the Medical Research Council (Grant Numbers MR/K021389/1 and MR/T003057/1 for MJ, TC and EJHJ), UKRI (Grant Number MR/S036423/1for EJHJ and TDB), and Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394 for the project AIMS-2-TRIALS. This Joint Undertaking receives support from the European Unionâs Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI. M-CL is supported by the Academic Scholars Award from the Department of Psychiatry, University of Toronto and the Canadian Institutes of Health Research Sex and Gender Science Chair (GSB 171373). The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. Any views expressed are those of the authors and not necessarily those of the funders.Funder: Canadian Institutes of Health Research Sex and Gender Science Chair (GSB 171373) Academic Scholars Award from the Department of Psychiatry, University of TorontoAbstractFace-processing timing differences may underlie visual social attention differences between autistic and non-autistic people, and males and females. This study investigates the timing of the effects of neurotype and sex on face-processing, and their dependence on age. We analysed EEG data during upright and inverted photographs of faces from 492 participants from the Longitudinal European Autism Project (141 neurotypical males, 76 neurotypical females, 202 autistic males, 73 autistic females; age 6â30Â years). We detected timings of sex/diagnosis effects on event-related potential amplitudes at the posteriorâtemporal channel P8 with Bootstrapped Cluster-based Permutation Analysis and conducted Growth Curve Analysis (GCA) to investigate the timecourse and dependence on age of neural signals. The periods of influence of neurotype and sex overlapped but differed in onset (respectively, 260 and 310Â ms post-stimulus), with sex effects lasting longer. GCA revealed a smaller and later amplitude peak in autistic female children compared to non-autistic female children; this difference decreased in adolescence and was not significant in adulthood. No age-dependent neurotype difference was significant in males. These findings indicate that sex and neurotype influence longer latency face processing and implicates cognitive rather than perceptual processing. Sex may have more overarching effects than neurotype on configural face processing.</jats:p